Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

942
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
942

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancements in extracellular vesicle research.

Extracellular vesicle·2026
Same author

Fabrication of Polyimide/Aluminum Nitride Composites and Wafer Channel Filling via Direct Ink Writing.

Nanomaterials (Basel, Switzerland)·2026
Same author

CardiOmicScore: a Multitask AI Model for Cardiovascular Disease Prediction.

Journal of cardiovascular translational research·2026
Same author

PSAP Protects Against Acute Myocardial Ischemia-Reperfusion Injury by Promoting ASAH1-Mediated Ceramide Metabolism.

Journal of cardiovascular translational research·2026
Same author

Influence of Sepsis on Clinical Outcomes During Mechanical Circulatory Support by Microaxial Flow Pump in Patients with Cardiogenic Shock Following Acute Myocardial Infarction.

Journal of clinical medicine·2026
Same author

Highly efficient tribocatalytic hydrogen peroxide production over Fe<sub>2</sub>O<sub>3</sub> nanoparticles and the reaction pathways.

Journal of colloid and interface science·2026

Related Experiment Video

Updated: Feb 18, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

1.2K

Extracellular Vesicles in Cardiovascular Theranostics.

Yihua Bei1, Saumya Das2, Rodosthenis S Rodosthenous2

  • 1Cardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.

Theranostics
|November 22, 2017
PubMed
Summary
This summary is machine-generated.

Extracellular vesicles (EVs) are crucial for cell communication and play significant roles in cardiovascular diseases (CVDs). This review explores their function, therapeutic potential, and use in regenerative medicine for CVDs.

Keywords:
Extracellular vesiclesbiomarkers.cardiovascular diseasesexosomesmicrovesiclestherapeutic agents

More Related Videos

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
08:32

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media

Published on: February 12, 2019

14.5K
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

15.1K

Related Experiment Videos

Last Updated: Feb 18, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

1.2K
Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
08:32

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media

Published on: February 12, 2019

14.5K
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

15.1K

Area of Science:

  • Cardiovascular Biology
  • Cell Biology
  • Biotechnology

Background:

  • Extracellular vesicles (EVs) are cell-derived vesicles involved in intercellular communication.
  • EVs are increasingly recognized for their regulatory roles in cardiovascular diseases (CVDs).
  • Cardiovascular EVs influence processes like cardiac hypertrophy, apoptosis, fibrosis, and angiogenesis.

Purpose of the Study:

  • To review the characteristics, isolation, and biological contents of EVs.
  • To elucidate the functional roles and pathophysiological effects of cardiovascular EVs in CVDs.
  • To summarize the potential of EVs as therapeutic agents, biomarkers, and drug delivery systems in CVDs and regenerative medicine.

Main Methods:

  • Literature review of current knowledge on EVs.
  • Focus on cardiovascular EVs derived from cardiomyocytes, endothelial cells, fibroblasts, and stem cells.
  • Discussion of EV isolation techniques, physical characteristics, and biological contents.

Main Results:

  • EVs mediate intercellular communication by transferring bioactive cargos and activating signaling pathways.
  • Cardiovascular EVs are implicated in the pathogenesis of various CVDs.
  • EVs show promise as therapeutic agents, diagnostic biomarkers, and drug delivery vehicles for CVDs.

Conclusions:

  • EVs are key players in cardiovascular pathophysiology and intercellular communication.
  • EVs offer significant potential for novel therapeutic strategies and regenerative medicine in CVDs.
  • Further research into EV applications could revolutionize CVD treatment and management.